William Gordon, MD
Otolaryngology · San Antonio, TXNPI 1205844297
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,500 of the $1,975 with a category attached, or 76.0%. Apria Healthcare LLC accounts for 76.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $1,539 and has fallen 97.6% since, to $38 in 2024. That places this record below the midpoint for otolaryngology clinicians in TX, where the typical reported total is $1,798.
Across 26 payments — averaging $75.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apria Healthcare LLC$2K
- Inspire Medical Systems, Inc.$143
- GSK$138
- Sanofi$68
- Optinose US, Inc.$53
- Zimmer Biomet$23
- plus $51 from 3 others
What the payments were for
- Speaking & faculty fees$1,50076%
- Food & beverage$47524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apria Healthcare LLC | 3 | $1,500 |
| Inspire Medical Systems, Inc. | 6 | $143 |
| GSK | 8 | $138 |
| Sanofi | 2 | $68 |
| Optinose US, Inc. | 3 | $53 |
| Zimmer Biomet | 1 | $23 |
| Stryker | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,975 in reported general payments places this provider in the 50th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 321 | $4,588 |
| Pantoprazole Sodium | 354 | $4,267 |
| Ofloxacin | 74 | $1,713 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 26 | $1,372 |
| Fluticasone Propionate | 65 | $888 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $270 |
| Cephalexin | 40 | $248 |
| Methylprednisolone | 24 | $218 |
| Triamcinolone Acetonide | 28 | $134 |
| Prednisone | 23 | $41 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in San Antonio
- Philip ChenSan Antonio$305K
- James AtkinsSan Antonio$205K
- Jeffrey RosenbloomSan Antonio$23K
- Jay FerrellSan Antonio$19K
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Jordan RihaniSouthlake$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.